Our NIH-funded team of basic science researchers and physician scientists develops novel cellular and molecular imaging solutions for pediatric patients with the goal to tackle significant problems encountered in clinical practice. We have extensive expertise in pre-clinical development and clinical translation of novel imaging technologies at the intersection of cell biology, nanomedicine and medical imaging: We introduced “one stop” imaging tests for detection of pediatric cancers with low or no radiation exposure (Lancet Oncology 2014), we developed theranostic nanoparticles for combined cancer imaging and therapy (Small 2014), and we developed patented techniques for stem cell tracking in patients (US14/161,315, US14/210,752). Over the past 10 years, our team members have received 77 honors and awards.